ethinyl estradiol has been researched along with Overweight in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
| Battaglia, B; Battaglia, C; Casadio, P; Guasina, F; Mattioli, M; Morotti, E | 1 |
| Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
| de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G | 1 |
| Bangerter, K; Merz, M; Reinecke, I; Westhoff, CL | 1 |
| Ellakwa, H; Gamal, A; Rezk, M; Sayyed, T; Zahran, A | 1 |
| Chang, HY; Chen, CH; Chen, HH; Chin, HY; Liu, WM | 1 |
| Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
| Adawadkar, SS; Arrowood, JA; Cheang, KI; Essah, PA; Nestler, JE; Stovall, DW | 1 |
| Harrison, C; Hutchison, SK; Meyer, C; Stepto, N; Teede, HJ | 1 |
1 review(s) available for ethinyl estradiol and Overweight
| Article | Year |
|---|---|
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
6 trial(s) available for ethinyl estradiol and Overweight
| Article | Year |
|---|---|
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases | 2013 |
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicular Phase; Follow-Up Studies; Humans; Lost to Follow-Up; Norpregnenes; Obesity; Oogenesis; Ovarian Follicle; Overweight; Ovulation Inhibition; Progesterone; Sex Hormone-Binding Globulin; Transdermal Patch; Ultrasonography; Young Adult | 2014 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Norgestrel; Obesity; Overweight; Placebo Effect; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Vasodilation; Virginia | 2011 |
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Contraceptives, Oral; Cyproterone; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Overweight; Polycystic Ovary Syndrome; Retinol-Binding Proteins, Plasma; Waist-Hip Ratio | 2008 |
4 other study(ies) available for ethinyl estradiol and Overweight
| Article | Year |
|---|---|
Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
Topics: Adolescent; Adult; Body Dysmorphic Disorders; Body Mass Index; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Italy; Overweight; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Weight Gain; Young Adult | 2017 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Metabolic changes in overweight and obese women above 35 years using Ethinylestradiol/drosperinone combined contraceptive pills: a 3-year case-control study.
Topics: Adult; Androstenes; Case-Control Studies; Ethinyl Estradiol; Female; Humans; Obesity; Overweight; Prospective Studies; Reproductive Control Agents | 2016 |
Pills-related severe adverse events: A case report in Taiwan.
Topics: Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Overweight; Polycystic Ovary Syndrome; Taiwan; Thromboembolism; Young Adult | 2016 |